NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Qayyum R, Wilson LM, Bolen S, et al. Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Sep. (Comparative Effectiveness Reviews, No. 14.)
This publication is provided for historical reference only and the information may be out of date.
Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes [Internet].
Show details| μg | Microgram |
| μmol/L | Micromol per liter |
| AA | African American |
| AHRQ | Agency for Healthcare Research and Quality |
| B | Baseline |
| BDI-II | Beck Depression Inventory - revised |
| B-F | Mean difference from baseline |
| BG | Blood glucose |
| BHI | Biphasic human insulin |
| BIAsp | Biphasic insulin aspart |
| BID | Twice daily |
| BMI | Body mass index |
| BS | Blood sugar |
| C | Caucasian |
| CGMS | Continuous glucose monitoring system |
| CI | Confidence interval |
| CINAHL | Cumulative Index to Nursing & Allied Health Literature |
| CNS | Central nervous system |
| CRP | C-reactive protein |
| CVD | Cardiovascular disease |
| D | Duration |
| DBP | Diastolic blood pressure |
| DCCT | Diabetes Control and Complications Trial |
| dl | Deciliter |
| DM | Diabetes mellitus |
| DTSQ | Diabetes Treatment Satisfaction Questionnaire |
| EMEA | European Medicines Agency |
| EPC | Evidence-based Practice Centers |
| EQ-5D | Euroqol-5D |
| F | Final |
| F-B | Mean difference from baseline |
| FBG | Fasting blood glucose |
| FDA | Food and Drug Administration |
| FPG | Fasting plasma glucose |
| g/day | Gram per day |
| GAD | Glutamic acid decarboxylase |
| GP | Group |
| GP1–GP2 | Mean difference between the difference from baseline |
| h | Hour |
| H | Hispanic |
| HgbA1c | Hemoglobin A1c |
| IHCIS | Integrated healthcare information services |
| IQR | Interquartile range |
| IU | International unit |
| kg | Kilogram |
| mg | Milligram |
| kg/m2 | Kilogram per square meter |
| L | Liter |
| lbs | Pounds |
| m | Meter |
| mg | Milligram |
| mg/dL | Milligram per deciliter |
| min | Minute |
| ml | Milliliter |
| mmHg | Millimeter of mercury |
| mmol | Millimole |
| NA | Not applicable |
| ng/mL | Nanograms per milliliter |
| NHIS | National health interview survey |
| NIH | National Institutes of Health |
| nmol | Nanomole |
| NPH | Neutral protamine hagedorn |
| NR | Not reported |
| NS | Not significant |
| OA | Oral antidiabetic |
| OAM | Oral antidiabetic medication |
| ODM | Oral diabetes medicine |
| OR | Odds ratio |
| p | P-value |
| PG | Plasma glucose |
| PPG | Postprandial glucose |
| qd | Once daily |
| RCTs | Randomized controlled trial |
| ref | Reference group |
| RR | Relative risk |
| SBP | Systolic blood pressures |
| SD | Standard deviation |
| SE | Standard error |
| SEM | Standard error of the mean |
| SU | Sulfonylurea |
| T | Time of day when insulin taken |
| T1DM | Type 1 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| TZD | Thiazolidinedione |
| U | Unit |
| UKPDS | United Kingdom Prospective Diabetes Study |
| ULN | Upper limit of normal |
| US | United States |
| v | Dosing varied |
| WHO-DTSQ | World Health Organization-Diabetes Treatment Satisfaction Questionnaire |
- List of Abbreviations - Comparative Effectiveness, Safety, and Indications of In...List of Abbreviations - Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes
- Receptor-type guanylate cyclase gcy-28 [Caenorhabditis elegans]Receptor-type guanylate cyclase gcy-28 [Caenorhabditis elegans]gi|1972228306|ref|NP_001380039.1|Protein
- IS66 family insertion sequence element accessory protein TnpB, partial [Lapidila...IS66 family insertion sequence element accessory protein TnpB, partial [Lapidilactobacillus gannanensis]gi|2818328519|ref|WP_379880630.1|Protein
- Methods - The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asth...Methods - The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management
- Results - Self-Measured Blood Pressure Monitoring: Comparative EffectivenessResults - Self-Measured Blood Pressure Monitoring: Comparative Effectiveness
Your browsing activity is empty.
Activity recording is turned off.
See more...